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Summary.-The effect of various mediators on the growth and secretion of IgE by
two human myeloma cell lines derived originally from the same tumour was tested.
It was found that the growth of U266 was unaffected by PGE2, but IgE secretion was
blocked. PGF2L, whilst inhibiting growth, had little effect on IgE secretion. With the
second cell line, U266 BL, it was found that none of the agents tested could modulate
the secretion of IgE, though cell growth was blocked by PGE2.
Prostaglandins act by modulating cyclic nucleotides, the E series increasing the
level of cAMP and the F series causing a rise in cGMP. Our findings with prosta-
glandins could be mimicked by the relevant cyclic mucleotide.
Possible explanations for these differences are discussed.
PROSTAGLANDINS exert their effect via
the cyclic-nucleotide pathway and, de-
pending on the tissue involved, increase or
decrease the synthesis of cAMP or cGMP
(Hinman, 1972).
Prostaglandins of the E series increase
cAMP levels in cultured cells such as
neuroblastoma (Gilman & Nirenberg,
1971) and fibroblasts (D'Armiento et al.,
1972; Manganiello & Vaughan, 1972) and
have also been shown to interfere with
division of Hela cells and plasma-cell
tumours (Adolphe et al., 1973; Naseem &
Hollander, 1973). More recently cAMP
has been shown to inhibit the growth of
tumour cells both in vitro and in vivo
(Cho-Chung, 1974). This and other evi-
dence (MacManus & Whitfield, 1969)
indicate that cyclic nucleotides play a role
in the regulation of cell metabolism and
growth (Johnson & Pastan, 1972).
The present report concerns the growth-
regulating properties of two prostaglan-
dins, PGE2 and PGF2a and the dibutyryl
derivatives of cAMP and cGMP on human
IgE myeloma cell lines U266 and U266 BL
(Nilsson et al., 1970). Of particular in-
terest is the observation that although
these lines originate from the same source,
the effects of the mediators are widely
different in each case.
MATERIALS AND METHODS
Myeloma cell line.-The U266 and U266 BL
cell lines were maintained in culture flasks
(500 ml) at an initial concentration of 2 x 105
cells/ml in RPMI 1640 supplemented with
10% foetal calf serum (FCS), 100 u/ml peni-
cillin, 0 1 g/l streptomycin in 5% C02 at
37°C. For long-term culture the medium was
changed twice weekly and the cell concentra-
tion adjusted to the initial concentration.
When testing forthe effect ofthepharmaco-
logical agents on growith and IgE production,
0-2 ml of cells was set up in flat-bottomed
microtitre plates (Sterilin Ltd) at a concentra-
tion of 2 x 105/ml and the agents were added
at the beginning of the culture period.
Chemical mediators-.Stock solutions of
prostaglandins (Sigma, London) were made
up to 10-4M concentration in RPMI 1640
medium containing 10% FCS. Stock solutions
of histamine and histamine agonists (Smith,
Kline and French Ltd, U.K.) were dissolved
in RPMI 1640 to 10-3M and diluted to the
required concentration with culture medium.
Indomethacin (Sigma, London) was used at a
dose (1 Hug/ml) that is known to block prosta-
glandin synthesis but not to interfere withC. CARINI, B. N. HUDSPITH AND J. BROSTOFF
other sensitive pathways to any significant
extent. Indomethacin wasdissolvedinethanol
and made up to the required concentration
with RPMI and 10% FCS. The final concen-
tration of ethanol in the culture was 0 02%.
Control cultures were set up with equivalent
concentrations of ethanol but lacking indo-
nmethacin. Dibutyryl cAMP and cGMP
(Sigma, London) weredissolved inRPMI 1640
containing FCS to the required concentra-
tions.
Cell counts and viability.-Cell numbers and
viability were assessed using acridine orange/
ethidium bromide staining and UV
microscopy.
Radioimmunoassay for IgE.-Sample cul-
ture supernatants were collected daily and
total IgE measured by a solid-phase radio-
immunoassay (Ceska & Lundkvist, 1972).
In brief, purified anti-human-IgE at a
concentration of 10 ,ug/ml was bound to
paper discs activated by cyanogen bromide
(Wide, 1969). Culture supernatants contain-
ing IgE were added, incubated and then
washed and 1251-anti-IgE added. A standard
curve of IgE (1-100 ng/ml) was included in
each assay.
Afterfurther washingthepercentage counts
bound was measured and the total IgE
calculated. With this method lng/ml levels
of IgE were measurable.
RESULTS
Cell viability and concentration ofmediators
Concentrations of agents were chosen
so that viability at the end of the 7-day
culture was not less than control viability.
The effective highest concentration of
histamine was 10-4M, ofPGE2 andPGF2u,
db-cAMP and db-cGMP was 10-6 M. Indo-
methacin was used at a concentration of
1 ug/ml.
Effect of mediators on growth of U266 and
U266 BL
Cell growth was followed daily for 6
days. When cells were cultured alone the
doubling time was 2-5 days (Fig. la). The
growth ofU266 was not affected by PGE2
and db-cAMP, whereas the lag phase of
tT266 BL in the presence of these agents
was increased (Fig. lb). The effect of
PGF2 mnd db-cGMP was to increase the
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FIG. 1.-Effect of mediators on myeloma-cell
growth. Histamine, PGE2 and dibutyryl
cAMP inhibited the growth of U266 BL
but had no detectable effect on U266.
Conversely, PGF2x and dibutyryl cGMP
were without effect on the growth of
U266 BL but completely blocked the
growth of U266. The mediators were used
at the highest level shown not to affect
viability over the culture period.
lag phase of U266 and reduce that of
U266 BL (Fig. lc). Histamine had no
effect on U266 and increased the lag phase
of U266 BL similarly to PGE2 and db-
cAMP, suggesting that histamine may be
acting via H2 receptors in regulating
growth. Indomethacin alone had no effect
on cell growth of either line.
Effect ofmediators on IgEsecretion by U266
and U266 BL
The production of IgE by U266 was
cyclical, peaking at 2 and 4 days, with a
trough in between. The cell line U266 BL
produced IgE continuously (Fig. 2a).
Both PGE2 and db-cAMP blocked secre-
tion of IgE by U266 and left unaffected
that of U266 BL (Fig. 2b). PGF2a, db-
cGMP, histamine and indomethacin had
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FIG. 2.-IgE secretion by U266 and U266BL.
The striking difference between the two cell
lines is that IgE production by U266 is
cyclical and that of U266 BL cumulative.
None of the various mediators had any
effect on IgE secretion by U266 BL, but
PGE2 and cAMP blocked secretion byU266,
there also being an apparent suppression
by PGF2o4 and db-cGMP. However, the cell
number in these cultures was reduced
(Fig. 1) and the IgE secretion per cell is
actually increased.
no effect on the secretion of IgE by either
cell line.
Decay ofpro8taglandin in tissue culture
When PGE2 and PGF2A were added to
the cells their presence was only detectable
for the first 24 h in culture (Fig. 3). Thus,
it appears that their effects persisted for
longer than was accountable for by their
presence in the culture medium.
DISCUSSION
Previous studies have suggested that
PGE2 inhibits the growth of a number of
tumour cell lines in vitro including plasma-
cytoma (Naseem & Hollander, 1973),
L51787 mouse leukaemia (Young et al.,
1976), human colorectal carcinoma (Tutton
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FIG. 3.-The decay of PGE2 (0) an(l PGF2cI
(*) in the culture supernatants was fol-
lowed using gas-liquid chromatography
and mass spectroscopy. It was found that
most of the agents had been metabolize(d
within the first 24 h of culture. Prosta-
glandin measurements on control cell super-
natants failed to detect any de novo syn-
thesis of PGE2 or PGF2cx by these cells.
Thus the effect of the PG persisted for
longer than was accountable for by theit
presence in the culture medium.
& Barkla, 1980) as well as Friend leuk-
aemia (Tabuse et al., 1977). Experimental
evidence also indicates that PGF2ax and
cGMP can have the effect of either
stimulating division of some cell lines or
inhibiting others (Tutton & Barkla, 1980).
Thus, transformed cells respond to en-
vironmental signals differently from their
normal counterpart. In certain cases this
appears to be due to the normal cell losing
sensitivity to some signals, so the remain-
ing control mechanisms appear to be
enhanced. An example of this can be seen
with the normal myeloid committed stem
cell, the CFU-C. This cell requires the
presence of the humoral substance colony
stimulating factor (CSF) to proliferate and
this proliferation is inhibited by PGE.
The tumour cell line WEHI-3, which is
derived from the CFU-C, has lost the
requirement for CSF, and so has an
apparent increased sensitivity to PGE
(Kurland & Moore, 1977).
Plasma cells and lymphoblastoid cells
are not sensitive to the effects of prosta-
glandins, whereas progenitor cells such as
circulating B lymphocytes are sensitive.
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Thus, prostaglandins seem to affect the
differentiation pathway of the cells, al-
though, surprisingly, these mediators are
not detectable for more than the first 24 h
of culture.
In the case of U266, PGE2 and PGF2ox
have profound effects on secretion of IgE
and growth of the cell line respectively,
whereas another cyclase activator, hist-
amine, was without effect. This implies
that PG receptors are selectively retained
by U266, as these effects can be mimicked
by the relevant cyclic nucleotides.
In the case ofU266 BL, where no change
in IgE secretion or growth is seen in the
presence of PGF2ax or cGMP, it would
seem that these cells express an expected
surface-receptor repertoire.
Thus, it is ofinterest that two cell lines
derived from the same original (IgE)
myeloma have differentiated to different
extents and maintained these differences
over several years. We may be looking at
two separate cell populations or the effect
of long-term culture on one of them.
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